Clinical Guides
Acute Mesenteric Ischaemia
A clinically focused emergency guide to acute mesenteric ischaemia in Indian practice, covering immediate CT angiography, phenotype-specific anticoagulation and revascularisation, bowel-viability surgery, sepsis care, transfer constraints and the limits of predominantly observational evidence.
MedNext Academy | 14 min read
Acute Mesenteric Ischaemia
A clinically focused emergency guide to acute mesenteric ischaemia in Indian practice, covering immediate CT angiography, phenotype-specific anticoagulation and revascularisation, bowel-viability surgery, sepsis care, transfer constraints and the limits of predominantly observational evidence.
Summary
Acute mesenteric ischaemia (AMI) is abrupt failure of intestinal blood flow sufficient to threaten bowel viability. The principal mechanisms are superior mesenteric arterial embolism, in-situ arterial thrombosis, non-occlusive mesenteric ischaemia (NOMI) during low-flow or vasoconstricted states, and mesenteric venous thrombosis (MVT). These mechanisms share abdominal pain and risk of infarction but require different definitive treatment. A normal early examination, modest lactate or apparently reassuring plain radiograph cannot exclude AMI. Pain that is unexpectedly severe for the initial abdominal findings remains a crucial warning, while peritonitis suggests established transmural injury until proved otherwise.
The safe pathway runs in parallel: recognise the vascular emergency, resuscitate without creating harmful delay, obtain biphasic CT angiography (CTA), start appropriate broad-spectrum antimicrobial cover and involve emergency surgery plus vascular or endovascular expertise. Intravenous contrast should not be withheld solely because renal function is impaired when AMI is genuinely suspected; missed or delayed bowel infarction is the more immediate threat. Unfractionated heparin is generally started unless contraindicated, but its purpose and urgency vary by phenotype and it never replaces reperfusion or resection.
Patients with peritoneal signs, perforation or unequivocally non-viable bowel require urgent exploration, restoration of flow where feasible and conservative resection of dead intestine. Selected patients without peritonitis may undergo endovascular-first reperfusion in a capable centre. MVT is often anticoagulated initially; NOMI requires correction of the precipitating low-flow state and specialist consideration of intra-arterial vasodilator treatment. Every step is time-critical and must be adapted to actual Indian CT, operating-theatre, vascular and transfer capability.
How Common Is It?
AMI is uncommon compared with appendicitis, obstruction or biliary disease, but its lethality makes it disproportionately important. The 2022 World Society of Emergency Surgery (WSES) guideline cites an estimated incidence of approximately 0.09–0.2% of acute surgical admissions and a mortality range of about 30–70%. These estimates arise largely from hospital cohorts in varied health systems, use non-uniform definitions and should not be presented as a contemporary Indian population rate. The burden rises with age and with cardiovascular disease, but younger adults can develop MVT, vasculitis, dissection or drug-associated vasoconstriction.
Arterial occlusive disease forms a substantial proportion of AMI in most series. Emboli often originate from the heart and lodge beyond the superior mesenteric artery origin; thrombosis commonly occurs on pre-existing ostial atherosclerosis. NOMI is encountered in critically ill patients receiving vasopressors or experiencing shock, severe cardiac failure or major surgery. MVT represents a smaller but clinically distinct group associated with local inflammation, thrombophilia, malignancy, cirrhosis and postoperative states. Aetiological proportions vary with referral patterns and diagnostic access.
India does not have a robust, current national AMI registry that permits a defensible incidence or outcome estimate. Tertiary centres will see a selected population, whereas early deaths or patients without CTA access may never enter published datasets. The practical epidemiological lesson is therefore not a precise number: AMI is rare enough to be overlooked, common enough to encounter in emergency practice and dangerous enough that an unexplained severe abdominal syndrome must trigger a deliberate vascular differential before irreversible injury develops.
Risk Factors
The mechanism should be anticipated from the risk profile. Arterial embolism is associated with atrial fibrillation, recent myocardial infarction, left-ventricular thrombus, valvular disease, endocarditis and aortic atheroma. Sudden pain in a person with an irregular pulse or an interruption in anticoagulation is particularly concerning. Arterial thrombosis is linked to diffuse atherosclerosis, smoking, diabetes, hypertension, dyslipidaemia, chronic mesenteric symptoms and previous vascular intervention. Postprandial pain, food avoidance and weight loss before an acute deterioration suggest thrombosis superimposed on chronic mesenteric ischaemia.
NOMI should be considered during cardiogenic, septic or hypovolaemic shock, severe heart failure, dialysis, major cardiac or abdominal surgery, profound dehydration and exposure to potent vasoconstrictors. The problem is splanchnic hypoperfusion rather than an obstructing clot, so escalating vasopressors without correcting perfusion may worsen injury. MVT risks include pancreatitis, intra-abdominal infection, inflammatory bowel disease, malignancy, portal hypertension, pregnancy or the puerperium, recent surgery, inherited thrombophilia and myeloproliferative neoplasms. In many patients, several risks coexist or no single cause is found.
Younger age must not produce false reassurance. Cocaine or other sympathomimetic exposure, vasculitis, antiphospholipid syndrome, sickle cell disease, inherited thrombophilia and arterial dissection can produce intestinal ischaemia. Older adults may present atypically with confusion, diarrhoea or collapse rather than a classic pain narrative. Medication review should include anticoagulants, antiplatelets, digoxin, diuretics, vasopressors, oestrogen exposure and drugs affecting volume status. Risk factors modify suspicion; their absence cannot safely rule AMI out.
Diagnosis
History
Ask when pain began, whether onset was abrupt, where it is felt, whether severity exceeds the apparent tenderness, and whether vomiting, diarrhoea, blood per rectum, distension or syncope followed. Establish preceding postprandial pain, reduced intake and weight loss; cardiac rhythm disease; thromboembolism; peripheral or coronary atherosclerosis; heart failure; shock; dialysis; cancer; thrombophilia; pancreatitis; inflammatory bowel disease; recent surgery; pregnancy; and vasoactive or recreational drug exposure. Record anticoagulant adherence and the last dose. A sedated or ventilated patient may show only unexplained acidosis, feeding intolerance, distension or organ deterioration.
Examination
Assess airway, breathing, circulation, mental state, perfusion and urine output while summoning senior help. Early abdominal findings may be mild despite severe pain. Later tenderness, guarding, rigidity, absent sounds or shock suggests infarction or perforation. Look for atrial fibrillation, cardiac failure, embolic stigmata and generalized arterial disease. Rectal blood supports mucosal injury but may be absent. Serial examination is useful only while definitive imaging and specialist action continue; repeated observation is unsafe when suspicion remains high.
Investigations
Perform biphasic CTA of arterial and venous mesenteric circulation without delay, including non-contrast assessment where the protocol supports it. It identifies occlusion, stenosis, venous thrombus, bowel enhancement, pneumatosis, portal venous gas, free fluid or perforation and helps plan reperfusion. Obtain blood count, electrolytes, renal and liver profile, glucose, coagulation, blood gas with lactate, type and crossmatch, ECG and cultures if septic. No laboratory biomarker, including lactate or D-dimer, independently confirms or excludes early AMI. Do not substitute ultrasound, plain radiography or a routine portal-venous CT for an adequate angiographic study.
Differential Diagnosis
Perforated peptic ulcer, appendicitis, acute pancreatitis, cholecystitis, cholangitis, diverticulitis, bowel obstruction, strangulated hernia and volvulus all cause acute abdominal pain and may progress to secondary peritonitis. Aortic aneurysm rupture, aortic dissection, renal infarction and acute limb or visceral embolism are vascular alternatives that may coexist with mesenteric disease. Inferior myocardial infarction, pulmonary embolism, lower-lobe pneumonia, diabetic ketoacidosis, adrenal crisis and severe metabolic disturbance can mimic an acute abdomen. In a person capable of pregnancy, ectopic pregnancy and adnexal torsion require urgent exclusion.
The CTA pattern helps separate AMI mechanisms. A discrete superior mesenteric arterial filling defect with relatively little ostial plaque favours embolism; ostial calcific disease with superimposed occlusion suggests thrombosis. Patent large vessels with bowel hypoperfusion in a shock or vasopressor setting supports NOMI, although interpretation requires clinical correlation. Mesenteric venous filling defects, bowel-wall oedema and mesenteric congestion support MVT. Pneumatosis alone is not synonymous with irreversible infarction because benign causes exist, but its combination with absent enhancement, portal venous gas, peritonitis or shock is highly concerning.
Chronic mesenteric ischaemia usually produces postprandial pain, food fear and weight loss rather than sudden infarction, yet acute-on-chronic thrombosis is common and can erase that distinction. Infectious gastroenteritis may cause pain, diarrhoea and raised lactate from dehydration; bloody diarrhoea must not automatically be labelled infection in an older or vascular-risk patient. The diagnostic discipline is to explain the entire physiology and imaging, not to stop at the first common abdominal diagnosis.
Management
Activate emergency general surgery and vascular or endovascular support as soon as AMI is suspected. Keep the patient nil by mouth, obtain large-bore venous access, provide oxygen when indicated, monitor continuously, catheterise for urine output when appropriate and correct hypoglycaemia, electrolyte disturbance and hypothermia. Give balanced crystalloid in reassessed boluses and blood products for haemorrhage or oxygen-carrying need; excessive fluid can worsen bowel oedema and abdominal pressure. Use vasopressors when required for perfusion after volume assessment, recognising that high-dose vasoconstriction can aggravate NOMI. Start broad-spectrum cover against enteric Gram-negative and anaerobic organisms because mucosal barrier failure occurs early.
Revascularisation should precede or accompany bowel assessment whenever feasible. In arterial embolism this may use surgical embolectomy or endovascular aspiration/thrombolysis; thrombosis may require angioplasty, stenting or bypass. Choice depends on anatomy, peritonitis, duration, bleeding risk and available expertise. Endovascular-first treatment is reasonable for selected patients without peritoneal signs in a capable centre, but transfer must not postpone laparotomy for infarcted bowel. At exploration, resect clearly necrotic intestine, preserve uncertain segments when safe, restore perfusion and plan a second-look operation when viability remains doubtful. Damage-control surgery may be appropriate in severe physiological failure.
MVT without peritonitis is usually managed with immediate therapeutic anticoagulation, supportive care and investigation of provoking factors; infarction requires surgery. NOMI management corrects the precipitating low-flow state, reduces avoidable vasoconstrictors and may include catheter-directed papaverine in specialist practice. Nutrition, short-bowel planning, stoma support and thrombosis follow-up become central after survival. Evidence comparing open, endovascular and hybrid pathways is predominantly observational, so multidisciplinary judgement is essential.
Prescribing Information
Unfractionated heparin is commonly preferred initially because it is rapidly titratable and reversible around urgent procedures. It is generally appropriate in AMI unless active major bleeding, profound coagulopathy, heparin-induced thrombocytopenia or another contraindication exists. MVT requires therapeutic anticoagulation even when bowel-wall haemorrhagic change is present, unless the treating team identifies a prohibitive bleeding risk. For arterial occlusion, anticoagulation limits propagation but must not delay reperfusion; for NOMI it is not a substitute for correcting shock and vasoconstriction. Dose, monitoring target and conversion to longer-term therapy must follow the institutional protocol, renal function and operative plan.
Empirical antimicrobial treatment should cover enteric Gram-negative bacilli and anaerobes, with broader coverage when healthcare exposure, shock, resistant-organism colonisation or local surveillance justifies it. Obtain cultures when useful without delaying therapy in sepsis, then narrow according to findings and source control. The NCDC national document provides Indian syndrome-based options, but an older national table cannot override the current hospital antibiogram, formulary, allergy history, renal or hepatic adjustment and local infectious-disease advice. Prolonged broad-spectrum therapy without an uncontrolled infectious source promotes resistance and toxicity.
Analgesia is necessary and does not invalidate examination. Avoid routine NSAIDs in shock, renal injury or high bleeding risk. Contrast exposure should be managed rather than used to deny urgent CTA: document renal risk, avoid additional nephrotoxins and reassess function. Thrombolysis has strict bleeding exclusions and belongs to an interventional pathway. Papaverine infusion for NOMI requires angiographic expertise and monitoring. This guide supports verification, not an individual prescription.
When to Refer
Suspected AMI is an emergency transfer, not a routine gastroenterology referral. Contact the nearest service that can provide immediate CTA interpretation, emergency laparotomy, critical care and either vascular surgery or interventional radiology. Communicate the time of symptom onset, physiological status, peritoneal signs, lactate trend, renal function, anticoagulants, CTA images and report, resuscitation given, and whether the receiving team can perform the likely reperfusion strategy. Transfer images electronically before movement where possible. A referral accepted without a named clinical handover or a realistic operative destination is not a completed pathway.
If the current hospital can perform emergency laparotomy but lacks endovascular capability, senior surgeons must decide whether operative source control and open revascularisation are safer than delay. Conversely, a stable patient without peritonitis and with a treatable occlusion may benefit from rapid transfer to a hybrid vascular centre. This is a time-and-capability decision; no universal distance threshold is safe. Continue monitoring, analgesia, anticoagulation when appropriate, antimicrobials and resuscitation during transfer, with trained escort and a plan for deterioration.
After the acute episode, refer arterial disease for vascular risk management and surveillance of a reconstruction or stent. MVT warrants evaluation for local causes and selective thrombophilia or myeloproliferative testing, guided by age, provoking factors and haematology advice rather than indiscriminate panels during the acute phase. Extensive bowel loss requires nutrition, intestinal-failure and stoma services. Persistent postprandial pain or weight loss after an apparently negative episode needs specialist reassessment because chronic or recurrent mesenteric ischaemia may remain.
Red Flags
Sudden severe abdominal pain that is disproportionate to initial tenderness is the classic early red flag. Additional danger features are atrial fibrillation, known atherosclerosis, recent embolism, interrupted anticoagulation, postprandial pain with weight loss, shock, vasopressor exposure, dialysis, unexplained metabolic acidosis, gastrointestinal bleeding or rapid organ deterioration. A normal lactate, normal leukocyte count or soft abdomen cannot safely close the diagnosis early. In an older patient, collapse, confusion or diarrhoea may be the presenting form.
Guarding, rigidity, rebound tenderness, progressive distension, absent bowel sounds, shock, worsening acidosis, pneumoperitoneum, portal venous gas with non-enhancing bowel, or perforation indicates advanced injury and demands immediate operative assessment. Do not wait for a second scan, serial lactates or a specialist ward round when peritonitis is present. Conversely, absence of peritonitis does not justify delay: viable bowel is rescued before these late signs appear. Deterioration during transfer requires direct escalation to the receiving surgical team and, if necessary, diversion to the nearest operative facility.
Treatment red flags include recurrent pain after transient improvement, rising vasopressor requirement, new bleeding on anticoagulation, compartment physiology, severe reperfusion instability and ongoing acidosis despite restored flow. After revascularisation, bowel that was initially equivocal may declare necrosis; planned second-look surgery is a safety strategy, not treatment failure. After discharge, recurrent postprandial pain, vomiting, bleeding, fever, dehydration or inability to maintain nutrition needs urgent reassessment. Any advice to return routinely while severe unexplained pain continues is unsafe.
Indian Clinical Context
Indian emergency pathways range from centres with round-the-clock multidetector CTA, vascular surgery and hybrid theatres to facilities without on-site radiology reporting, interventional capability or critical care beds. The clinical standard remains urgent vascular imaging and definitive treatment, but the route must be engineered around what is actually available. Early telephone escalation, direct image transfer, a named receiving surgeon, ambulance capability and avoidance of repetitive low-yield tests can save more time than adding another local observation period. When CTA is unavailable, transfer should begin on clinical suspicion rather than waiting for late peritonitis.
Renal dysfunction, distance and cost frequently become reasons to postpone contrast imaging. WSES explicitly states that CTA should be performed despite acute kidney injury when AMI is suspected because delayed diagnosis has far greater immediate consequences. Explain that trade-off honestly and mitigate nephrotoxins and hypovolaemia without making renal optimisation a prerequisite. A routine contrast CT acquired without arterial phase may miss the vascular lesion; radiology requests should say suspected mesenteric ischaemia and ask for the appropriate angiographic protocol.
Empirical antibiotics must reflect Indian resistance patterns. Use the current hospital antibiogram and NCDC stewardship principles, obtain cultures when they can change care and de-escalate after operative findings and microbiology. Do not promote a single national drug recipe across community, district and tertiary hospitals. Limited endovascular access does not make prolonged anticoagulation alone appropriate for arterial occlusion with threatened bowel. Document delays, transfer barriers and the basis of decisions. Published AMI evidence remains heavily observational and is not India-specific, so outcome claims and claims of one universally superior technique would be misleading.
NMC Competency Mapping
This guide maps most directly to NMC General Surgery competency SU27.1, which covers the aetiopathogenesis, clinical features, investigations and principles of treatment of occlusive arterial disease, and to SU28.3, which covers causes, clinical features, complications and management principles of peritonitis. AMI sits at their clinically important intersection: vascular occlusion can progress to intestinal gangrene and diffuse peritoneal contamination. The learner should obtain a focused history, perform respectful abdominal and cardiovascular examination, identify physiological instability, formulate a mechanism-based differential and request correct urgent imaging under supervision. Safe prescribing, communication and referral principles provide horizontal integration.
At the knowledge and application level, students should distinguish arterial embolism, arterial thrombosis, NOMI and MVT; explain why early pain can exceed physical findings; recognise that lactate is neither sensitive nor specific early; and interpret the purpose of biphasic CTA. They should understand resuscitation, enteric antimicrobial cover, therapeutic anticoagulation, revascularisation, bowel-viability assessment and second-look surgery as linked components rather than isolated facts. A simulation can test escalation and handover when local vascular capability is absent.
Clinical performance requires supervised practice. Reading this guide does not certify independent CTA interpretation, anticoagulant initiation, thrombolysis, mesenteric angiography, laparotomy or bowel-viability judgement. Learners should demonstrate closed-loop referral, documentation of contraindications and communication of uncertainty. Assessment should reward time-critical action and avoidance of false reassurance, while recognising that evidence for several interventions is low certainty. Institutions should confirm these mappings against their adopted 2024 CBME implementation. The patient-safety outcome is a graduate who considers AMI early and mobilises the correct team without pretending to deliver specialist treatment alone.
Key Exam Pearls for NEET PG
AMI classically presents with severe abdominal pain out of proportion to early examination findings. Superior mesenteric arterial emboli are associated with atrial fibrillation and often lodge distal to the origin; in-situ thrombosis commonly develops on ostial atherosclerosis and may follow chronic postprandial pain and weight loss. NOMI occurs in low-flow or vasoconstricted states with patent major vessels. MVT is associated with thrombophilia, malignancy, inflammatory abdominal disease and portal hypertension and is treated primarily with anticoagulation when infarction is absent.
CTA is the diagnostic test of choice and should not be delayed for a normal lactate or withheld solely because acute kidney injury is present. An angiographic protocol evaluates arterial and venous phases and bowel viability. Plain radiography is neither sensitive nor definitive. Late imaging signs include absent mural enhancement, dilatation, pneumatosis, portal venous gas and free air; their meaning depends on the combined clinical pattern. Peritonitis indicates probable irreversible bowel injury and mandates urgent exploration.
Initial treatment includes resuscitation, broad enteric antimicrobial cover, analgesia, early unfractionated heparin unless contraindicated, and immediate surgical plus vascular/endovascular involvement. Arterial occlusion requires rapid reperfusion; dead bowel requires conservative resection. Endovascular treatment suits selected patients without peritonitis where expertise exists, while open or hybrid approaches remain necessary in others. NOMI treatment reverses the low-flow cause and may use catheter-directed vasodilator therapy. Second-look surgery reassesses questionable bowel. The examination trap is choosing serial observation because pain, lactate or the first abdominal examination seems insufficiently dramatic.
Frequently Asked Questions
Can a normal blood lactate safely exclude early acute mesenteric ischaemia?
No. Lactate may remain normal before extensive infarction and can rise for many other reasons, including shock or seizures. It contributes to physiological assessment and trending but cannot rule AMI in or out. Persistent clinical suspicion requires properly protocoled CT angiography and urgent surgical involvement, not reassurance from one laboratory value.
Should CT angiography wait until impaired kidney function has been corrected?
No when AMI is genuinely suspected. WSES recommends CTA without delay even with acute kidney injury because missed intestinal infarction is the greater immediate threat. Clinicians should correct hypovolaemia, avoid additional nephrotoxins and monitor renal function, but these measures should occur alongside rather than before time-critical vascular imaging.
Does every patient with acute mesenteric ischaemia require immediate laparotomy?
No. Peritonitis, perforation or non-viable bowel requires urgent exploration. Selected patients without peritoneal signs may receive endovascular-first arterial reperfusion, MVT may be anticoagulated, and NOMI may improve after perfusion correction with specialist vasodilator therapy. The phenotype, bowel viability, stability and local capability determine the route.
Is anticoagulation alone definitive treatment for an acute mesenteric arterial occlusion?
Usually not. Heparin helps prevent propagation and is commonly started unless contraindicated, but an arterial embolus or thrombosis threatening bowel generally requires rapid revascularisation. Anticoagulation is primary therapy for many cases of MVT without infarction. It must never delay surgery when peritonitis or necrotic bowel is suspected.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic